8-K
Current Report
Aclaris Therapeutics, Inc. Filed Acc 0001558370-20-007743
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading tmb-20200623x8k.htm…